IP Library Granted Patent US 7,297,342
Granted Patent B2
US 7,297,342 · App. 10/517,378 · Granted Nov 20, 2007

Orthopaedic materials derived from keratin

Assignee: Keratec Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,297,342
App. No.
10/517,378
Granted
Nov 20, 2007
Kind
B2
Abstract

The invention provides a biocompatible material derived from keratin that is useful for many aspects of medical treatment of bone. The keratin material is preferably S-sulfonated and enriched in intermediate filament proteins of high molecular weight. The keratin material may be porous for use as a bone replacement and augmentation product but also provided is the use of dense keratin materials in bone treatment for use as an internal fixation appliance in the treatment of bone fractures and bone regeneration, and a method for preparing the keratin material for use in the preservation, restoration and development of form and function of bone.

Claims (3)

1. A porous spongy material for bone grafting application comprising S-sulfonated keratin and hydroxyapatite in a weight ratio of S-sulfonated keratin to hydroxyapatite ranging from 1:0.1 to 1:2, respectively, where the S-sulfonated keratin is optionally treated with a reducing agent to remove sulfonate functionality and provide disulfide crosslinks.

2. A process for preparing the porous spongy material of claim 1 comprising the steps of forming an aqueous solution of S-sulfonated keratin, suspending hydroxyapatite in the S-sulfonated keratin solution at a weight ratio of S-sulfonated keratin to hydroxyapatite ranging from 1:0.1 to 1:2, respectively, and then freeze drying.

3. The process of claim 2 comprising the additional steps of treating the freeze dried material with a reducing agent to remove sulfonate functionality from the S-sulfonated keratin and form disulfide crosslinks, washing to remove the reducing agent and freeze drying the washed material.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Sep 18, 2025
From: KMS VENTURES, LLC
To: KERAPLAST TECHNOLOGIES, LLC
Reel/Frame 072298/0313 →
SECURITY AGREEMENT Recorded Oct 15, 2013
From: KERAPLAST TECHNOLOGIES, LLC
To: KMS VENTURES, INC.
Reel/Frame 031411/0609 →
SECURITY AGREEMENT Recorded Jun 4, 2010
From: KERAPLAST TECHNOLOGIES, LLC
To: KMS VENUTRES, INC.
Reel/Frame 024483/0526 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2009
From: KERATEC LIMITED
To: KERAPLAST TECHNOLOGIES, LTD.
Reel/Frame 022328/0419 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2005
From: PEPLOW, PHILIP VICTOR; DIAS, SUBASINGHA NISANKE GEORGE PREMALAL JAYANTHA; RODDICK-LANZILOTTA, ALISA DAWN; KELLY, ROBERT JAMES
To: KERATEC LIMITED
Reel/Frame 016440/0878 →
Priority Claims (1)
NZ 519456 · Jun 10, 2002 · national
Continuity (1)
Related Publication 20050232963A1 · Oct 20, 2005